Pediatr Infect Vaccine.
2022 Aug;29(2):105-109. 10.14776/piv.2022.29.e11.
Successful Treatment of VancomycinResistant Enterococcus Bacteremia With a Combination of Daptomycin and Tigecycline in an Infant who Underwent Heart-Lung Transplantation
- Affiliations
-
- 1Department of Pediatrics, Pusan National University Children’s Hospital, Yangsan, the Republic of Korea
- KMID: 2538274
- DOI: http://doi.org/10.14776/piv.2022.29.e11
Abstract
- The treatment of invasive infections caused by multidrug-resistant vancomycin-resistant enterococci (VRE) is challenging, particularly in pediatric patients with underlying medical conditions. Newer antibiotics used to treat VRE infections in pediatric patients are insufficiently studied. This report presents the case of a 6-month-old infant who underwent heart–lung transplantation and was successfully treated with a combination of daptomycin and tigecycline for recurrent VRE bacteremia shortly after the discontinuation of linezolid.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
- Successful Treatment of VancomycinResistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents
- A Case of Pyelonephritis Accompanied by Enterococcus hirae Bacteremia
- Optimizing the Dosing Regimens of Tigecycline against VancomycinResistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections
- Recent Advancement in Heart and Lung Transplantation
